Skip to content
Publish & Distribute
Publishing Solutions
Distribution Solutions
Library Services
Subjects
Architecture and Design
Arts
Business and Economics
Chemistry
Classical and Ancient Near Eastern Studies
Computer Sciences
Cultural Studies
Engineering
General Interest
Geosciences
History
Industrial Chemistry
Jewish Studies
Law
Library and Information Science, Book Studies
Life Sciences
Linguistics and Semiotics
Literary Studies
Materials Sciences
Mathematics
Medicine
Music
Pharmacy
Philosophy
Physics
Social Sciences
Sports and Recreation
Theology and Religion
Publications
Journals
Books
Proceedings
Publishers
Journal Matcher
Blog
Contact
Search
English
English
Deutsch
Polski
Español
Français
Italiano
Cart
Home
Journals
Acta Pharmaceutica
Volume 73 (2023): Issue 2 (June 2023)
Open Access
Efficacy of BNT162b2 and CoronaVac in patients diagnosed with COVID-19
Mustafa Dogan
Mustafa Dogan
Tekirdag Corlu State Hospital Department of Infection Diseases and Clinical Microbiology
Tekirdag, Turkey
Orcid profile
Search for this author on
Sciendo
|
Google Scholar
Dogan, Mustafa
and
Berna Yilmaz
Berna Yilmaz
Manisa City Hospital Department of Anesthesiology Reanimation and Intensive Care Manisa
Turkey
Orcid profile
Search for this author on
Sciendo
|
Google Scholar
Yilmaz, Berna
Jun 12, 2023
Acta Pharmaceutica
Volume 73 (2023): Issue 2 (June 2023)
About this article
Previous Article
Next Article
Abstract
References
Authors
Articles in this Issue
Preview
PDF
Cite
Share
Download Cover
Published Online:
Jun 12, 2023
Page range:
257 - 268
Accepted:
Mar 03, 2023
DOI:
https://doi.org/10.2478/acph-2023-0020
Keywords
COVID-19
,
anti-COVID-19 vaccine
,
BNT162b2 (Pfizer-BioNTech)
,
CoronaVac (Sinovac) vaccine efficacy
© 2023 Mustafa Dogan et al., published by Sciendo
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.